Pediatric PsO guidelines offer management pearls
New joint AAD-NPF guidelines consider the quality-of-life impact of pediatric psoriasis as well as comorbidity risks in this patient population.
 
ADVERTISEMENT
Guidance on transitioning PsO patients between biologics
Switching patients with moderate-to-severe plaque psoriasis from one biologic to another is a multifactorial decision and may depend on safety, efficacy or dosing intervals. Ron Vender, M.D., offers insight into how to switch appropriately.
ADVERTISEMENT